Purdue Pharma and the Sackler family that own the company have agreed to a $7.4 billion settlement in principle with 15 states over its role in the opioid crisis.
The prior authorization was denied. What’s more, in an unusual move, the insurer declined to allow a “peer-to-peer” review of her case between her physician and one working for her insurer.
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every ...